“leerink-partners” Archives

in
Entry Author Date Location
No Details, But AstraZeneca Touts PARP Drug Win in Pancreatic Cancer 02/26/19 New York
With New Results, FibroGen’s Anemia Pill Inches Closer to FDA Review 12/20/18 San Francisco
FDA Halts Clinical Test of Zafgen Diabetes Drug, Stock Price Tumbles 11/26/18 Boston
Illumina Set to Acquire “Long-Read” DNA Sequencer PacBio for $1.2B 11/01/18 San Diego
Report: Express Scripts Shuts Out Teva Migraine Drug, Prefers Rivals 10/17/18 National
FDA, Following EMA, Nixes Amicus’ Plans for Speedy OK of Pompe Drug 09/10/18 New York
Precision Bio Lands $110M as Gene-Edited Cell Therapy Nears Clinic 06/27/18 Raleigh Durham
Exact Sciences, Mayo Clinic Share Data on DNA-Based Liver Cancer Test 06/06/18 Wisconsin
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines 05/17/18 National
Verdine Picks Backers For FogPharma’s $66M Round, Keeping Firm Control 05/16/18 Boston
Safety Concerns Linger for Lilly’s Arthritis Drug as FDA Panel Looms 04/19/18 Indiana
Fresh Off $25M Raise, Generation Adds $100M For Next-Gen Gene Therapy 02/27/18 Boston
Aimmune’s Peanut Allergy Drug Hits Study Goals, FDA Filing Planned 02/20/18 San Francisco
Avrobio Raises $60M for Fabry Disease Gene Therapy, Rest of Pipeline 02/01/18 Boston
In Week of Hemophilia News, Alnylam Drug Cleared to Move Forward 12/15/17 Boston
Acorda Scraps One Parkinson’s Drug, Puts Its Cash Behind Another 11/20/17 New York
Acorda Takes Another Hit, Reports Patient Deaths in Parkinson’s Study 11/15/17 New York
Sage Bounces Back, Eyes FDA Filing for Postpartum Drug 11/09/17 Boston
Five Prime Shares Dive on Latest Hiccup For Cancer Immunotherapy Combos 11/07/17 San Francisco
Leerink’s Cozzens on New Health IT Fund, A.I.’s Future as a Platform 10/20/17 Boston
Boston Tech Watch: Leerink, E14 Fund, Jobcase, Freight Farms & More 09/29/17 Boston
Ultragenyx Makes Competing Bid for Gene Therapy Biotech Dimension Tx 09/18/17 San Francisco
Amicus’s Scioderm Deal Flops as Skin Drug Fails in Phase 3 09/13/17 New York
All Eyes on Depression Trials as Sage Neuro Drug Flunks Epilepsy Test 09/12/17 Boston
Novo Nordisk Diabetes Drug Beats Lilly’s Trulicity in Head-to-Head Test 08/17/17 Indiana
Immunotherapy Shakeup: AstraZeneca Inks Merck Deal as Drug Combo Fails 07/27/17 National
Biogen, Opening Bottlenecks, Sees Spine Drug Sales, Shares Rise 07/25/17 Boston
Celgene’s Data Could Lead To New Option For Multiple Sclerosis Patients 05/22/17 New York
FDA Wants More Safety Info on Psych Drug, Intra-Cellular Shares Drop 05/01/17 New York
Will New Data Open “Bottlenecks” For Biogen’s Pricey Spine Drug? 04/26/17 Boston
Page 1 of 3 next page »